AVA TherapeutiX

AVA TherapeutiX

NextGenMonoclonals® identified in AVA NewTechnology are further developed in AVATherapeutiX for precision therapy approaches. The focus is not only on their direct use as therapeutic mAbs, but also on the use of mAb derivatives. In particular, CAR-T-cell based immunotherapy is at the center of our interest.

Image